Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | CASP3 | P42574 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.46 |
| ▸ | RELA | Q04206 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.46 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.46 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | POLB | P06746 | 4/20 | 0.45 |
| ▸ | ESR1 | P03372 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26259566 | 0.89 | POLB (0.48) | KDM4EKMT2AHSD17B10MEN1MAPT | |
| SCHEMBL26259380 | 0.84 | KDM4E (0.48) | KDM4EKMT2AHSD17B10MEN1MAPT | |
| SCHEMBL20740270 | 0.83 | TDP1 (0.44) | KDM4EKMT2AHSD17B10MEN1MAPT | |
| SCHEMBL30386272 | 0.83 | TDP1 (0.44) | KDM4EKMT2AHSD17B10MEN1MAPT | |
| SCHEMBL24309030 | 0.82 | TDP1 (0.49) | KDM4EKMT2AHSD17B10MEN1MAPT | |
| SCHEMBL26259720 | 0.78 | ALDH1A1 (0.54) | KDM4EKMT2AHSD17B10MEN1MAPT | |
| SCHEMBL19662084 | 0.78 | TDP1 (0.47) | KDM4EKMT2AHSD17B10MEN1MAPT | |
| SCHEMBL1310537 | 0.77 | KMT2A (0.62) | KDM4EKMT2AHSD17B10MEN1MAPT | |
| SCHEMBL22124455 | 0.76 | KDM4E (0.41) | KDM4EKMT2AHSD17B10MEN1MAPT | |
| SCHEMBL16398511 | 0.75 | ALDH1A1 (0.42) | KDM4EKMT2AHSD17B10MEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112521531-A | Olefin polymerization catalyst component, preparation method thereof, olefin polymerization catalyst and polymerization method | 中国石油天然气股份有限公司 | 2021-03-19 | — | — | CN | claimed |
| US-20130123266-A1 | TREATMENT OF A PATHOLOGY LINKED TO AN EXCESSIVE EFFECT OF TNF WITH A BENZENE SULPHONAMIDE COMPOUND | VAX-CONSULTING (FR) | 2013-05-16 | — | — | US | claimed |
| US-20230287262-A1 | PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2023-09-14 | — | — | US | disclosed |
| CN-112521531-B | Olefin polymerization catalyst component, preparation method thereof, olefin polymerization catalyst and polymerization method | 中国石油天然气股份有限公司 | 2022-12-02 | — | — | CN | disclosed |
| US-11370967-B2 | Light emitting apparatus and electronic device comprising light emitting apparatus | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-06-28 | — | — | US | disclosed |
| US-11289654-B2 | Polymers containing furanyl crosslinkable groups and uses thereof | GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD. (CN) | 2022-03-29 | — | — | US | disclosed |
| EP-3465332-B1 | LIGHT EMITTING APPARATUS AND ELECTRONIC DEVICE COMPRISING THE SAME | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-07-21 | — | — | EP | disclosed |
| US-20210186927-A1 | COMBINATION PRODUCT FOR THE INDUCTION AND/OR MAINTENANCE OF GENERAL ANESTHESIA | TERRAN BIOSCIENCES, INC. | 2021-06-24 | — | — | US | disclosed |
| CN-112521531-A | Olefin polymerization catalyst component, preparation method thereof, olefin polymerization catalyst and polymerization method | 中国石油天然气股份有限公司 | 2021-03-19 | — | — | CN | disclosed |
| US-20200317999-A1 | LIGHT EMITTING APPARATUS AND ELECTRONIC DEVICE COMPRISING THE SAME | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-10-08 | — | — | US | disclosed |
| US-20200299573-A1 | COMPOSITE COMPRISING SEMICONDUCTOR NANOCRYSTALS AND METHOD OF PREPARING THE SAME | ROHM AND HAAS ELECTRONIC MATERIALS LLC | 2020-09-24 | — | — | US | disclosed |
| US-5489505-A | ON A SUPPORT ATLEAST ONE SILVER HALIDE EMULSION AND ATLEAST ONE METHINE DYE; STORAGE STABILITY AND HIGH SENSITIVITY | FUJI PHOTO FILM CO., LTD. (JP) | 1996-02-06 | — | — | US | disclosed |
| US-5459029-A | Photographic element hardened with imidazolium hardeners | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-10-17 | — | — | US | disclosed |
| US-5433896-A | FLUORESCENT | MOLECULAR PROBES, INC. (US) | 1995-07-18 | — | — | US | disclosed |
| US-5378842-A | Aminocarbonyl derivatives | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-01-03 | — | — | US | disclosed |
| WO-1993018016-A1 | FUNGICIDAL OXAZOLIDINONES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-09-16 | — | — | WO | disclosed |
| EP-0397364-B1 | HETEROCYCLIC GUANIDINES AS 5HT 3 ANTAGONISTS | PFIZER INC. (US) | 1993-07-28 | — | — | EP | disclosed |
| US-5035984-A | Computer output images, nucleating agent | FUJI PHOTO FILM CO., LTD. (JP) | 1991-07-30 | — | — | US | disclosed |
| EP-0397364-A1 | Heterocyclic guanidines AS 5HT 3 Antagonists | PFIZER INC. (US) | 1990-11-14 | — | — | EP | disclosed |
| US-4963689-A | ANTIEMETICS, ANALGESICS, GASTROINTESTINAL DISORDERS, SCHIZOPHRENIA | PFIZER INC. (US) | 1990-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210186927-A1 | COMBINATION PRODUCT FOR THE INDUCTION AND/OR MAINTENANCE OF GENERAL ANESTHESIA | OPRK1, OPRD1, GABRD | KDM4E 1235/4885KMT2A 733/4885HSD17B10 3880/4885 |
| US-20130123266-A1 | TREATMENT OF A PATHOLOGY LINKED TO AN EXCESSIVE EFFECT OF TNF WITH A BENZENE SULPHONAMIDE COMPOUND | TNF, TNFRSF1A, TRAF6 | KDM4E 3466/4885KMT2A 3647/4885HSD17B10 1595/4885 |
| US-20200317999-A1 | LIGHT EMITTING APPARATUS AND ELECTRONIC DEVICE COMPRISING THE SAME | CRY1, CRY2, LAGE3 | KDM4E 2596/4885KMT2A 1072/4885HSD17B10 3512/4885 |
| US-20230287262-A1 | PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND | NUDC, CCNL2, SPIN3 | KDM4E 1663/4885KMT2A 3312/4885HSD17B10 4034/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.